The family Gallant earned €120 million in 2021 through the company Goodgrowerarray of Vithas, the second largest hospital group in Spain. The company returns to profit after having lost 28.6 million in 2020, in the year of the start of the Covid-19 pandemic.
The group turnover also improved by about 20%reaching 626 million, according to the consolidated accounts presented by the group recently in the Mercantile Registry.
The Gallardo family is known for being the founders and largest shareholders of the listed laboratory Almirall. In addition to this pharmaceutical company, the second generation (Gallardo Gallart) has the Goodgrower company -with which it controls the Vithas hospital group- and the corporation landon -the family office which ensures that the family patrimony is made profitable–.
Goodgrower collects in its accounts a huge increase in financial income, up to 120.8 million, which explains the jump in profit. Specifically, this extra financial income corresponds to its French subsidiary Francegrower, but it does not detail what the increase is due to. The company did not respond to this newspaper’s request for information to explain the increase. According to the accounts, this result is not distributed as a dividend and is transferred to voluntary reserves.
Vithas is the second hospital group in Spain after QuirónSalud (of the German group Fresenius). It has 19 hospitals and 22 medical centers with 1,872 beds. It employs 5,632 people and is present in 13 provinces (Madrid, Valencia, Malaga, Seville, Alicante, Pontevedra, Álava, Granada, Castellón, Lleida, Santa Cruz de Tenerife, Las Palmas and Almería).
The group advances in its accounts that will invest 90 million in two new hospitals: the third of Valencia –this time to the south of the city, in the Malilla neighborhood– and his first in Barcelona, to which it will allocate 60 million, located in Baix Llobregat. “Catalonia is a strategic territory for our growth and expansion plans, so I am confident that the new hospital in Barcelona will be the spearhead of new future investments that we are already exploring,” he said. Rich Petergeneral director of Vithas, in the presentation of the landing in that province.
Currently, the group’s largest hospitals are 9 de Octubre in Valencia (221 beds), Vigo (151 beds), Seville (144), Las Palmas (139) and La Milagrosa in Madrid (127), which it bought in 2020 to the Congregation of the Pauline Fathers. Part of the growth in recent years comes from the purchase of its rival Nisa, in which Goodgrower increased its participation last year to control 78.86% of its capital.
The Gallardos control 100% of Vithas through Goodgrower after they acquired 93 million in 2020 with 20% of Criteria Caixa, which exercised a sale option for the agreement sealed by the then partners in 2011.
At the head of Goodgrower stands Jorge Gallardo Pique as president, member of the third generation of the family and brother of Charles Gallardocurrent president and interim CEO of Almirall.
In the Goodgrower accounts, PwC collects qualifications in the auditsince it warns that the company does not include information on salaries, allowances and remuneration for the year and the previous year for senior management personnel and the board of directors.